BLRX
NASDAQ
IL
BioLineRx Ltd. - American Depositary Shares
$2.21
▲ +$0.03
(+1.38%)
Vol 12K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$41.8M
ROE
-16.1%
Margin
-23.4%
D/E
58.25
Beta
0.28
52W
$1–$8
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2024 | — | $-0.07 | — |
| Mar 2024 | — | $-0.01 | — |
| Sep 2023 | — | $-0.30 | — |
| Sep 2015 | $-0.08 | $-0.12 | $-0.04 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $4.9M | $11.7M | $255K | $304K | $427K |
| Net Income | -$5.8M | -$3.2M | $5.1M | -$3.9M | -$977K |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -49.7% | -23.9% | -49.7% | -49.7% | -16.1% | -16.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1296.0% | -15.2% | -45.3% | -45.3% | -23.4% | -23.4% |
| Gross Margin | 76.3% | 64.9% | 59.3% | 59.3% | 50.7% | 50.7% |
| D/E Ratio | 62.79 | 65.87 | 62.79 | 62.79 | 58.25 | 58.25 |
| Current Ratio | 2.06 | 2.27 | 2.06 | 2.06 | 2.09 | 2.09 |
Key Ratios
ROA (TTM)
-7.2%
P/S (TTM)
1.03
P/B
2.0
EPS (TTM)
$0.00
CF/Share
$-0.18
52W High
$7.90
52W Low
$1.40
$1.40
52-Week Range
$7.90
Financial Health
Free Cash Flow
-$2.1M
Net Debt
$3.5M
Cash
$7.9M
Total Debt
$11.4M
As of Sep 30, 2025
How does BLRX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BLRX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.0
▼
92%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
2.0
▼
19%
below
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BLRX profitability vs Biotechnology peers
ROE
-16.1%
▲
76%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-23.4%
▲
92%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
50.7%
▼
36%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-7.2%
▲
85%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
BLRX financial health vs Biotechnology peers
D/E ratio
58.3
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
2.1
▼
53%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼
71%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
BLRX fundamentals radar
BLRX
Peer median
Industry
BLRX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BLRX vs peers: key metrics
Top Holders
Top 5: 1.05%Citadel Advisors Llc
0.84%
$87K
Rhumbline Advisers
0.08%
$8K
Citigroup Inc.
0.05%
$5K
UBS Group AG
0.04%
$5K
Wells Fargo & Company
0.04%
$4K
As of Dec 31, 2025
Latest News
No related news yet